WallStreetZenWallStreetZen

NASDAQ: CTKB
Cytek Biosciences Inc Stock Ownership - Who owns Cytek Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytek Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Wenbin JiangPRESIDENT AND CEO2025-08-185,382$4.06
$21.85kSell
Ming YanCHIEF TECHNOLOGY OFFICER2025-08-181,468$4.06
$5.96kSell
Ming YanCHIEF TECHNOLOGY OFFICER2025-08-182,184$4.06
$8.87kSell
Philippe BusqueSVP GLOBAL SALES AND SERVICES2025-08-18599$4.06
$2.43kSell
Philippe BusqueSVP GLOBAL SALES AND SERVICES2025-08-18861$4.06
$3.50kSell
Philippe BusqueSVP GLOBAL SALES AND SERVICES2025-08-181,412$4.06
$5.73kSell
Wenbin JiangPRESIDENT AND CEO2025-08-182,869$4.06
$11.65kSell
Wenbin JiangPRESIDENT AND CEO2025-08-181,646$4.06
$6.68kSell
Ming YanCHIEF TECHNOLOGY OFFICER2025-08-18588$4.06
$2.39kSell
Ming YanCHIEF TECHNOLOGY OFFICER2025-08-181,498$4.06
$6.08kSell

1 of 6

CTKB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTKB insiders and whales buy or sell their stock.

CTKB Shareholders

What type of owners hold Cytek Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc13.39%17,035,535$67.12MInstitution
Ra Capital Management LP10.52%13,381,054$52.72MInsider
Wenbin Jiang6.27%7,981,017$31.45MInsider
Vanguard Group Inc6.10%7,765,138$30.59MInstitution
Brown Capital Management LLC5.59%7,109,995$28.01MInstitution
Hhlr Advisors Ltd5.23%6,657,030$26.23MInstitution
Ming Yan4.76%6,057,419$23.87MInsider
Topline Capital Management LLC4.11%5,231,260$20.61MInstitution
State Street Corp3.28%4,173,763$16.44MInstitution
Dimensional Fund Advisors LP2.72%3,454,806$13.61MInstitution

1 of 3

CTKB vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTKB62.41%22.36%Net SellingNet Selling
KIDS43.27%56.73%Net SellingNet Buying
VREX92.64%1.65%Net SellingNet Selling
ZIMV85.73%12.44%Net SellingNet Selling
SRDX60.84%39.16%Net Selling
View Top Medical Device Stocks

Cytek Biosciences Stock Ownership FAQ

Who owns Cytek Biosciences?

Cytek Biosciences (NASDAQ: CTKB) is owned by 62.41% institutional shareholders, 22.36% Cytek Biosciences insiders, and 15.24% retail investors. Ra Capital Management LP is the largest individual Cytek Biosciences shareholder, owning 13.38M shares representing 10.52% of the company. Ra Capital Management LP's Cytek Biosciences shares are currently valued at $52.99M.

If you're new to stock investing, here's how to buy Cytek Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.